Effects of MEDI0382, a glucagon-like peptide 1/glucagon receptor dual agonist, on pancreatic and incretin hormones

被引：0
|
作者：
Jermutus, L. [1 ]
Tsai, L. -F. [2 ]
Robertson, D. [1 ]
Petrone, M. [1 ]
Rondinone, C. [2 ]
Boaz, H. [2 ]
Ambery, P. [1 ]
Parker, V. [1 ]
机构：
[1] MedImmune, Cambridge, England
[2] MedImmune, Gaithersburg, MD USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
778
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [1] Cotadutide (MEDI0382), a dual receptor agonist with balanced glucagon-like peptide-1 and glucagon activity, modulates hepatic glycogen stores
    Parker, V. E.
    Robertson, D.
    Hansen, L.
    Ambery, P. D.
    Esterline, R.
    Jermutus, L.
    Chang, Y. -T.
    Petrone, M.
    Johansson, E.
    Johansson, L.
    Sjoberg, F.
    Hirshberg, B.
    DIABETOLOGIA, 2019, 62 : S58 - S59
  • [2] Cotadutide (medi0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Modulates Hepatic Glycogen and Fat Content
    Robertson, Darren
    Hansen, Lars
    Ambery, Philip
    Esterline, Russell L.
    Jermutus, Lutz
    Chang, Yi-Ting
    Petrone, Marcella
    Johansson, Edvin
    Johansson, Lars
    Sjoberg, Folke B.
    Parker, Victoria
    DIABETES, 2020, 69
  • [3] Effects of MEDI0382 on Pancreatic and Incretin Hormones
    Parker, Victoria E. R.
    Tsai, Lan-Feng
    Robertson, Darren
    Petrone, Marcella
    Rondinone, Cristina
    Hirshberg, Boaz
    Jermutus, Lutz
    Ambery, Philip
    DIABETES, 2018, 67
  • [4] MEDI0382, a glucagon-like peptide 1/glucagon receptor dual agonist, significantly reduces hepatic fat content in subjects with type 2 diabetes
    Jain, M.
    Tsai, L. -F.
    Robertson, D.
    Hirshberg, B.
    Hockings, P.
    Johansson, L.
    Ambery, P.
    DIABETOLOGIA, 2018, 61 : S353 - S353
  • [5] MEDI0382, a glucagon-like peptide/glucagon receptor dual agonist, in patients with type 2 diabetes: a multiple-ascending-dose study
    Robertson, D.
    Stumvoll, M.
    Posch, M.
    Heise, T.
    Plum-Moerschel, L.
    Klein, G.
    Tsai, L. -F.
    Petrone, M.
    Hirshberg, B.
    Rondinone, C.
    Parker, V.
    Jermutus, L.
    Ambery, P.
    DIABETOLOGIA, 2018, 61 : S348 - S348
  • [6] The Dual Glucagon-Like Peptide-1 (GLP-1)/Glucagon Receptor Agonist MEDI0382 Improves Metabolic and Hepatic Indices of NASH in Mice
    Trevaskis, James
    Beaton, Michelle L.
    Bednarek, Maria
    Hornigold, David C.
    Naylor, Jacqui
    Collinson, Andie
    Veidal, Sanne Skovgaard
    Madsen, Andreas Nygaard
    Ambery, Philip
    Henderson, Simon
    Coghlan, Matthew P.
    Grimsby, Joseph
    Rhodes, Christopher
    Jermutus, Lutz
    Konkar, Anish
    HEPATOLOGY, 2016, 64 : 751A - 751A
  • [7] Effect of MEDI0382, a Glucagon-like Peptide 1/Glucagon Receptor Dual Agonist, on Hepatic Fat and Relationship to Metabolomic Changes in Overweight or Obese Subjects with Type 2 Diabetes Mellitus
    Jain, Meena
    Trevaskis, James
    Boland, Michelle L.
    Conway, James
    Tsai, Lan-Feng
    Hirshberg, Boaz
    Jermutus, Lutz
    Ambery, Philip
    HEPATOLOGY, 2018, 68 : 436A - 437A
  • [8] Cotadutide (MEDI0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Is Well Tolerated (<600 μG) with Robust Effects on Blood Glucose in Patients with T2DM
    Robertson, Darren
    Hansen, Lars
    Jain, Meena
    Parker, Victoria
    Petrone, Marcella
    Wang, Tao
    Heise, Tim
    Jermutus, Lutz
    DIABETES, 2020, 69
  • [9] MEDI0382, a GLP-1/glucagon receptor dual agonist, improves NASH and reduces liver fibrosis in mice
    Trevaskis, J. L.
    Boland, M. L.
    Conway, J.
    Guionaud, S.
    Grimsby, J.
    Jermutus, L.
    Rhodes, C. J.
    DIABETOLOGIA, 2018, 61 : S590 - S590
  • [10] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2019, 68
12345